Trial Profile
A Phase 2, Stratified, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of MGAWN1 in Subjects with Laboratorydocumented West Nile Fever or Suspected Central Nervous System Infection Due to West Nile Virus.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Oct 2010
Price :
$35
*
At a glance
- Drugs MGAWN1 (Primary)
- Indications West Nile virus infections
- Focus Adverse reactions; Therapeutic Use
- 07 Oct 2010 New trial record